-
2025/10/18 Experience of Polymyxin B hemoperfusion for Severe sepsis
Eun Young Kim (The Catholic University of Korea)
- Prof. Kim Eun Young
- Associate Professor / Division of Trauma and Surgical Critical Care, Department of Surgery
- Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Biography：
Prof. Kim Eun Young has been serving as an Associate Professor in the Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary’s Hospital, the Catholic University of Korea since 2017, and she is currently an active member of the Korean Society of Critical Care Medicine.
She is particularly active in research on extracorporeal blood purification therapies for patients with septic shock. Her major contributions in this area include the publication of,
1. “Extracorporeal Blood Purification Treatments for Refractory Septic Shock Following Surgery” at Journal of Acute Care Surgery (2025),
2. “Diagnostic Value of Endotoxin Activity for Acute Postoperative Complications: A Study in Major Abdominal Surgery Patients“ at Biomedicines (2024),
3. “The clinical efficacy and suitable implementation of two extracorporeal blood purification therapies: AN69-oXiris versus PMX-HP“ at Frontiers in Medicine (2024),
4. “Usefulness of bioelectrical impedance analysis and ECW ratio as guidance for fluid management in critically ill patients after surgery” at Scientific Reports (2021),
and 5. “Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock” at World Journal of Gastrointestinal Surgery (2019).
Prof. Kim Eun Young has been serving as an Associate Professor in the Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary’s Hospital, the Catholic University of Korea since 2017, and she is currently an active member of the Korean Society of Critical Care Medicine.
She is particularly active in research on extracorporeal blood purification therapies for patients with septic shock. Her major contributions in this area include the publication of,
1. “Extracorporeal Blood Purification Treatments for Refractory Septic Shock Following Surgery” at Journal of Acute Care Surgery (2025),
2. “Diagnostic Value of Endotoxin Activity for Acute Postoperative Complications: A Study in Major Abdominal Surgery Patients“ at Biomedicines (2024),
3. “The clinical efficacy and suitable implementation of two extracorporeal blood purification therapies: AN69-oXiris versus PMX-HP“ at Frontiers in Medicine (2024),
4. “Usefulness of bioelectrical impedance analysis and ECW ratio as guidance for fluid management in critically ill patients after surgery” at Scientific Reports (2021),
and 5. “Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock” at World Journal of Gastrointestinal Surgery (2019).